Short-term Outcomes of Different Techniques for Gastric Ischemic Pre-Conditioning Before Esophagectomy: A Network Meta-Analysis. Aiolfi A, Bona D, Bonitta G, Bonavina L, Cayre L, Guerrazzi G, Gutschow CA, Lipham J, Manara M, Popa C, Rausa E, Schlanger D, Schoppmann S, Simić A, Sozzi A, Zehetner J; Gastric Ischemic Conditioning (GIC) International Collaborative Group Ann Surg. 2023 Oct 13. doi: 10.1097/SLA.0000000000006124. Online ahead of print.
Effective Laparoscopic Paraesophageal Hernia Repairleads to an increased in Life-Expectancy over Watchful Waiting in asymptomatic patients. DeMeester SR, Bernard L, Schoppmann SF, Kloostermann R, Roth JS Ann Surg. 2023 Oct 11. doi: 10.1097/SLA.0000000000006119. Online ahead of print.
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma. Puhr HC, Weirauch CC, Selimi F, Oberreiter K, Dieterle MA, Jomrich G, Schoppmann SF, Prager GW, Berghoff AS, Preusser M, Ilhan-Mutlu A.J Cancer Res Clin Oncol. 2023 Dec;149(19):17081-17091. doi: 10.1007/s00432-023-05424-4. J Cancer Res Clin Oncol. 2023 Dec;149(19):17081-17091. doi: 10.1007/s00432-023-05424-4. Epub 2023 Sep 26.
Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction. Feka J., Jomrich G., Asari R., Schoppmann SF. Langenbecks Arch Surg. 2023 Sep 6;408(1):351. doi: 10.1007/s00423-023-03093-y.
Safety and short-term efficacy of patients with GERD and ineffective esophageal motility treated with RefluxStop™ device implantation– a multicentric observational study. Feka J.*, Boyle N.+, Saad M.*, Kristo I.*, Asari R.*, **Schoppmann SF*. Updates Surg 2023, Jul, under revision
Effect of gastric ischemic conditioning prior to esophagectomy: systematic review and meta-analysis. Aiolfi A, Bona D, Bonitta G, Bonavina L; Gastric Ischemic Conditioning (GIC) International Collaborative Group. Updates Surg. 2023 Sep;75(6):1633-1643. doi: 10.1007/s13304-023-01601-9
The impact of ineffective esophageal motility on patients undergoing magnetic sphincter augmentation. Baison GA, Jackson AS, Wilshire CL, Bell RCW, Lazzari V, Bonavina L, Ayazi S, Jobe BA, Schoppmann SF, Dunn CP, Lipham JC, Dunst CM, Farivar AS, Bograd AJ, Louie BE. Ann Surg Ann Surg. 2023 Apr 1;277(4):e793-e800. doi: 10.1097/SLA.0000000000005369.
Standardization of rectal cancer surgery and bowel preparation in Austria: A multicenter nationwide survey by the Austrian Society of Surgical Oncology. Widmann KM, Dawoud C, Harpain F, Aigner F, Presl J, Rosen H, Zitt M, Schoppmann SF, Emmanuel K, Riss S. Wien Klin Wochenschr. 2023 Sep;135(17-18):457-462. doi: 10.1007/s00508-023-02227-y.
Is magnetic sphincter augmentation indicated in patients with laryngopharyngeal reflux? Schoppmann SF. Dis Esophagus 2023 Jun 15;36(Supplement_1):doad012. doi: 10.1093/dote/doad012.
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy. Gensthaler L, Jomrich G, Brugger J, Kollmann D, Paireder M, Bologheanu M, Horn A, Riegler FM, Asari R, Schoppmann FS. Langenbecks Arch Surg, 2023 Jun 6;408(1):227. doi: 10.1007/s00423-023-02938-w.
Management of paraesophageal hiatus hernia: recommendations following a European expert Delphi consensus. Gerdes S, Schoppmann SF, Bonavina L, Boyle N, Müller-Stich BP, Gutschow CA. Surg Endoscopy, 2023 un;37(6):4555-4565. doi: 10.1007/s00464-023-09933-8.
Improving the Diagnostic Yield of High-Resolution Esophageal Manometry of GERD: The “Straight Leg-Raise” International Study. Siboni S, Kristo I, Rogers BD, De Bortoli N, Hobson A, Louie B, Lee YY, Tee V, Tolone S, Marabotto E, Visaggi P, Haworth J, Ivy M, Greenan G, Facchini C, Masuda T, Yano F, Perry K, Balasubramanian G, Theodorou D, Triantafyllou T, Cusmai L, Boveri S, Schoppmann SF, Gyawali CP, Bonavina L. Clin Gastroenterol Hepatol 2023 Jul;21(7):1761-1770.e1. doi: 10.1016/j.cgh.2022.10.008.
RefluxStop TM Therapy- a new minimally invasive Technology in Anti reflux surgery. Stephan D, Borbely Y, Schoppmann SF
Surg Technol Int 2022, Oct 17:41:sti41/1622. Online ahead of print.
Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score). Puhr HC, Puhr R, Kuchling DA, Jahic L, Takats J, eiter TJ, Paireder M, Jomrich G, Schoppmann SF, Berghoff AS, Preusser M, Ilhan-Mutlu A. ESMO Open 2022 Aug;7(4):100519. doi: 10.1016/j.esmoop.2022.100519.
Severe dysphagia is a rare problem after magnetic sphincter augementation. Bologheanu M, Matic A, Feka J, Asari R, Bologheanu R, Riegler FM, Gensthaler L, Osmokrovic B, Schoppmann SF. World J Surg. 2022 Sep;46(9):2243-2250. doi: 10.1007/s00268-022-06573-2.
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumor boards in Europe. Tiuri E Kroesse, Richard van Hillegersber, Sebastian Schoppmann, Pieter R A J Deseyne, Philippe Nafteux et al. Eur J Cancer. 2022 Mar:164:18-29. doi: 10.1016/j.ejca.2021.11.032
Rates of Anastomotic Complications and their Management Following Esophagectomy: Results of the Oesophago-Gastric-Anastomosis Audit (OGAA). Oesophago-Gastric Anastomosis Study Group on behalf of the west midlands research Collaborative. Ann Surg 2022 Feb 1;275(2):e382-e391. doi: 10.1097/SLA.0000000000004649.
Expanded Indication for Magnetic Sphincter Augmentation: Outcomes in Weakly Acidic Reflux Compared to Standard GERD Patients. Milena Nikolic, Aleksa Matic, Joy Feka, Lisa Gensthaler, Ivan Kristo, Bogdan Osmokrovic, Franz M. Riegler, Berta O. Mosleh & Sebastian F. Schoppmann. J Gastrointest Surg. 2022 Mar;26(3):532-541. doi: 10.1007/s11605-021-05152-5.
Meta-analysis of randomized controlled trials and individual patient data comparing minimally invasive with open oesophagectomy for cancer. B. P. Müller-Stich, P. Probst, H. Nienhüser, S. Fazeli, J. Senft, E. Kalkum, P. Heger, R. Warschkow, F. Nickel, A.T. Billeter, P. P. Grimminger, C. Gutschow, T. S. Dabakuyo-Yonli, G. Piessen, M. Paireder, S. F. Schoppmann, D. L. van der Peet, M. A. Cuesta, P. van der Sluis, R. van Hillegersberg, A. H. Hölscher, M. K. Diener, T. Schmidt. Br J Surg. 2021 Sep 27;108(9):1026-1033. doi: 10.1093/bjs/znab278.
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment. Gerd Jomrich, Dagmar Kollmann, Dariga Ramazanova, Robin Ristl, Richard P Grose, Aysegül Ilhan-Mutlu, Matthias Preusser, Christina Fassnacht, Yi-Chien Tsai, Emmanuella Guenova, Sebastian F Schoppmann. Eur J Surg Oncol. 2022 Feb;48(2):383-390. doi: 10.1016/j.ejso.2021.08.016.
Additional fundophrenicopexia, after Nissen fundoplication, reduces postoperative dysphagia and re-operation rate in the long-term follow up. Milena Nikolic, Aleksa Matic, Ivan Kristo, Matthias Paireder, Reza Asari, Bogdan Osmokrovic, Georg Semmler & Sebastian F. Schoppmann. Surg Endosc. 2022 May;36(5):3019-3027. doi: 10.1007/s00464-021-08598-5.
Tumor cell budding in preoperative biopsies of esophageal and gastroesophageal junction carcinoma independentliy survival in a grade-dependent manner. Beer Andrea, Reber Annabell, Paireder Matthias, Schoppmann Sebastian F., Heber Stefan, Schiefer, Ana-Iris, Surgery (United States), 2022 Aug;172(2):567-574. doi: 10.1016/j.surg.2022.02.020.
Three-year clinical experience wit magnetic sphincter augmentation and laparoscopic fundoplication. Bonavina L, Horbach T, Schoppmann SF, DeMarchi J. Surgical Endoscopic. 2021 Jul;35(7):3449-3458. doi: 10.1007/s00464-020-07792-1.
Erratum: Exploring the concept of centralization of surgery for benign esophageal diseases: A Delphi based consensus from the European Society for Diseases of the Esophagus. Lugaresi M, Nafteux P, Nilsson M, Reynolds J, Rosati R, Schoppmann S.F., Targarona E, Mattioli S. Dis Esophagus. 2021 Aug 10;34(8):doab024. doi: 10.1093/dote/doab024.
The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease. Bonavina, Luigia; Boyle, Nick; Schoppmann, Sebastian F. Curr Opin Gastroenterol. 2021 Jul 1;37(4):384-389. doi: 10.1097/MOG.0000000000000748
Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy. Gerd Jomrich, Dagmar Kollmann, Lavinia Wilfing, Sanja Radosavljevic, Dariga Ramazanova, Robin Ristl, Richard P. Grose, Aysegül Ilhan-Mutlu, Matthias Preusser, Christina Fassnacht, Yi-Chien Tsai, Emmanuella Guenova MD, PhD & Sebastian F. Schoppmann MD. Eur Surg. 2021;53(6):287-293. doi: 10.1007/s10353-021-00700-4.
Thyroid Hormone Replacement Therapy Is Associated With Longer Overall Survival in Patients With Resectable Gastroesophageal Cancer-a Retrospective Single Center Analysis. Hannah Christina Puhr, Thorsten J Reiter, Mohamed El-Mahrouk, Lena Saliternig, Peter Wolf, Maximilian J Mair, Ariane Steindl, Matthias Paireder, Reza Asari, Sebastian F Schoppmann, Anna S Berghoff, Matthias Preusser, Ayseguel Ilhan-Mutlu. Cancers (Basel), 2021 Oct 9;13(20):5050. doi: 10.3390/cancers13205050.
Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing. Christiane Kulinna-Cosentini, Michael A. Arnoldner, Wolfgang Schima, Ivan Kristo, Sebastian F. Schoppmann, Michael Weber & Enrico P. Cosentini. Eur Radiol. 2021 Nov;31(11):8578-8585. doi: 10.1007/s00330-021-07927-5.
Corrigendum to: Exploring the concept of centralization of surgery for benign esophageal diseases: a Delphi based consensus from the European Society for Diseases of the Esophagus. Marialuisa Lugaresi, Philippe Nafteux, Magnus Nilsson, John V Reynolds, Riccardo Rosati, Sebastian F Schoppmann, Eduardo M Targarona, Sandro Mattioli. Dis Esophagus. 2021 Aug 10;34(8): doab024. doi: 10.1093/dote/doab024.
Vorstellung einer prospektiv andomisierten Multicenterstudie zum Vergleich der Hiatusplastik mit Nähten vs. Nähte mit Pledget vs. Resorbierbares Netz bei großen Hiatushernien. Koch O, BHA von Rahden, H Wykpiel, SF Schhoppmann, R Függer et al. Zentralbl Chir. 2021 Apr;146(2):204-209. doi: 10.1055/a-1369-9694.
High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Jomrich, Gerd; Paireder, Matthias; Kristo, Ivan; Baierl, Andreas; Ilhan-Mutlu, Ayseguel, Preusser, Matthias, Asari, Reza; Schoppmann, Sebastian F. Ann Surg. 2021 Mar 1;273(3):532-541. doi: 10.1097/SLA.0000000000003370.
Exploring the concept of centralization of surgery for benign esophageal diseases: a Delphi based consensus from the European Society for Diseases of the Esophagus. Marialuisa Lugaresi, Philippe Nafteux, Magnus Nilsson, John V Reynolds, Riccardo Rosati, Sebastian F Schoppmann, Eduardo M Targarona, Sandro Mattioli. Dis Esophagus. 2021 Sep 9;34(9):doab013. doi: 10.1093/dote/doab013.
Electrical stimulation therapy of the lower esophageal sphincter in GERD patients—a prospective single-center study. Matthias Paireder MD, Ivan Kristo MD, Milena Nikolic MD, Gerd Jomrich MD, Johannes Steindl, Erwin Rieder MD, Reza Asari MD & Sebastian F. Schoppmann MD, F.A.C.S. European Surgery volume 53, pages 29–34 (2021)
Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, Schoppmann SF. Surg Endosc. 2021 Nov;35(11):6101-6107. doi: 10.1007/s00464-020-08104-3.
Alternative und operative Verfahren zur Behandlung der gastroösophagealen Refluxerkrankungen // Alternative surgical anti-reflux Procedures. Schoppmann, SF. Zentralbl Chir. 2021 Apr;146(2):210-214. doi: 10.1055/a-1369-9732.Esophageal resection in Austria—preparing a national registry. Matthias Paireder, Reza Asari, Wolfgang Radlspöck, Anna Fabbri, Andreas Tschoner, Reinhold Függer, Johannes Zacherl, Sebastian F. Schoppmann. European Surgery volume 53, pages206–214 (2021) https://doi.org/10.1007/s10353-021-00734-8
Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Bonavina L, Horbach T, Schoppmann SF, DeMarchi J.Surg Endosc. 2021 Jul;35(7):3449-3458. doi: 10.1007/s00464-020-07792-1. Epub 2020 Jul 16. PMID: 32676727
The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease. Bonavina L, Boyle N, Schoppmann SF. Curr Opin Gastroenterol. 2021 Jul 1;37(4):384-389. doi: 10.1097/MOG.0000000000000748. PMID: 33883422
High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Schoppmann SF. Ann Surg. 2021 Mar 1;273(3):532-541. doi: 10.1097/SLA.0000000000003370. PMID: 31425286
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment. Jomrich G, Kollmann D, Ramazanova D, Ristl R, Grose RP, Ilhan-Mutlu A, Preusser M, Fassnacht C, Tsai YC, Guenova E, Schoppmann SF. Eur J Surg Oncol. 2021 Aug 11:S0748-7983(21)00686-7. doi: 10.1016/j.ejso.2021.08.016. PMID: 34404561
Planning and Design of a Prospective Randomised Multi-Centre Trial on the Repair of Large Hiatal Hernias with Sutures vs. Pledgeted Sutures vs. Absorbable Mesh. Koch O, von Rahden BHA, Wykypiel H, Schoppmann SF, Függer R, Rosanelli G, Emmanuel K, Weitzendorfer M. Zentralbl Chir. 2021 Apr;146(2):204-209. doi: 10.1055/a-1369-9694. Epub 2021 Feb 10. PMID: 33567462 Clinical Trial.
Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing. Kulinna-Cosentini C, Arnoldner MA, Schima W, Kristo I, Schoppmann SF, Weber M, Cosentini EP. Eur Radiol. 2021 Nov;31(11):8578-8585. doi: 10.1007/s00330-021-07927-5. Epub 2021 Apr 24. PMID: 33893856
Exploring the concept of centralization of surgery for benign esophageal diseases: a Delphi based consensus from the European Society for Diseases of the Esophagus. Lugaresi M, Nafteux P, Nilsson M, Reynolds JV, Rosati R, Schoppmann SF, Targarona EM, Mattioli S. Dis Esophagus. 2021 Sep 9;34(9):doab013. doi: 10.1093/dote/doab013. PMID: 33621318
Meta-analysis of randomized controlled trials and individual patient data comparing minimally invasive with open oesophagectomy for cancer. Müller-Stich BP, Probst P, Nienhüser H, Fazeli S, Senft J, Kalkum E, Heger P, Warschkow R, Nickel F, Billeter AT, Grimminger PP, Gutschow C, Dabakuyo-Yonli TS, Piessen G, Paireder M, Schoppmann SF, van der Peet DL, Cuesta MA, van der Sluis P, van Hillegersberg R, Hölscher AH, Diener MK, Schmidt T. Br J Surg. 2021 Sep 27;108(9):1026-1033. doi: 10.1093/bjs/znab278. PMID: 34491293
Additional fundophrenicopexia, after Nissen fundoplication, reduces postoperative dysphagia and re-operation rate in the long-term follow up. Nikolic M, Matic A, Kristo I, Paireder M, Asari R, Osmokrovic B, Semmler G, Schoppmann SF. Surg Endosc. 2021 Jun 22. doi: 10.1007/s00464-021-08598-5. Online ahead of print. PMID: 34159461
Expanded Indication for Magnetic Sphincter Augmentation: Outcomes in Weakly Acidic Reflux Compared to Standard GERD Patients. Nikolic M, Matic A, Feka J, Gensthaler L, Kristo I, Osmokrovic B, Riegler FM, Mosleh BO, Schoppmann SF. J Gastrointest Surg. 2021 Sep 29. doi: 10.1007/s11605-021-05152-5. PMID: 34590216
Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility. Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, Schoppmann SF. Surg Endosc. 2021 Nov;35(11):6101-6107. doi: 10.1007/s00464-020-08104-3. Epub 2020 Oct 30. PMID: 33128080
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis. Puhr HC, Reiter TJ, El-Mahrouk M, Saliternig L, Wolf P, Mair MJ, Steindl A, Paireder M, Asari R, Schoppmann SF, Berghoff AS, Preusser M, Ilhan-Mutlu A.Cancers (Basel). 2021 Oct 9;13(20):5050. doi: 10.3390/cancers13205050. PMID: 34680197
Alternative Surgical Anti-Reflux Procedures. Schoppmann SF. Zentralbl Chir. 2021 Apr;146(2):210-214. doi: 10.1055/a-1369-9732. Epub 2021 Apr 13. PMID: 33851383
Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility. Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, Schoppmann SF. Surg Endosc. 2020 Oct 30. PMID: 33128080.
A PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study. Beer, A; Taghizadeh, H; Schiefer, AI; Puhr, HC; Karner, AK; Jomrich, G; Schoppmann, SF; Kain, R; Preusser, M; Ilhan-Mutlu. Pathol Oncol Res. 2020 Oct;26(4):2225-2235. PMID: 32372174.
Achalasia: physiology and diagnosis. Rieder, E; Fernandez-Becker, NQ; Sarosiek, J; Guillaume, A; Azagury, DE; Clarke, J. Ann NY Acad Sci. 2020 Dec;1482(2):85-94. PMID: 33140485.
A Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. Puhr, HC; Karner, A; Taghizadeh, H; Jomrich, G; Schoppmann, SF; Preusser, M; Ilhan-Mutlu. J Cancer Res Clin Oncol. 2020 Dec;146(12):3313-3322. PMID: 32617700.
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Paireder, M; Jomrich, G; Kristo, I; Asari, R; Rieder, E; Beer, A; Ilhan-Mutlu, A; Preusser, M; Schmid, R; Schoppmann, SF. Strahlenther Onkol. 2020 Sep;196(9):779-786. PMID: 32055873.
Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Bonavina, L; Horbach, T; Schoppmann, SF; DeMarchi, J. Surg Endosc. 2020 Jul 16. PMID: 32676727
Electrical stimulation therapy of the lower esophageal sphincter in GERD patients – a prospective single-center study. Paireder M, Kristo I, Nikolic M, Jomrich G, Steindl J, Rieder E, Asari R, Schoppmann SF. Eur Surg 53, 29–34 (2021). doi.org/10.1007/s10353-020-00678-5.
Do we understand the pathophysiology of GERD after sleeve gastrectomy? Felinska, E; Billeter, A; Nickel, F; Contin, P; Berlth, F; Chand, B; Grimminger, P; Mikami, D; Schoppmann, SF; Muller-Stich, B. Ann N Y Acad Sci. 2020 Dec;1482(1):26-35. PMID: 32893342
Fibroblast growth factor 8 overexpression is predictive of poor prognosis in pancreatic ductal adenocarcinoma. Jomrich, G; Wilfing, L; Radosavljevic, S; Parak, A; Winkler, D; Timelthaler, G; Schindl, M; Schoppmann, SF; Klosch, B. Eur Surg 52, 282–289 (2020). https://doi.org/10.1007/s10353-020-00669-6.
Silent Gastroesophageal Reflux Disease in Patients with Morbid Obesity Prior to Primary Metabolic Surgery. Kristo, I; Paireder, M; Jomrich, G; Felsenreich, DM; Fischer, M; Hennerbichler, FP; Langer, FB; Prager, G; Schoppmann, SF. Obes Surg. 2020 Dec;30(12):4885-4891. PMID: 32910407.
Ineffective Esophageal Motility in Patients with GERD is no Contraindication for Nissen Fundoplication. Nikolic, M; Schwameis, K; Kristo, I; Paireder, M; Matic, A; Semmler, G; Semmler, L; Schoppmann, SF. World J Surg. 2020 Jan;44(1):186-193. PMID: 31605176.
Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis. Puhr, HC; Wolf, P; Berghoff, AS; Schoppmann, SF; Preusser, M; Ilhan-Mutlu, A. Horm Cancer. 2020 Feb;11(1):42-51. PMID: 31884578.
Utilization and Efficacy of Palliative Chemotherapy for Locally Advanced or Metastatic Gastroesophageal Carcinoma. Baumgartner, R; Taghizadeh, H; Jomrich, G; Schoppmann, SF; Preusser, M; Ilhan-Mutlu, A. Anticancer Res. 2020 Feb;40(2):965-975. PMID: 32014941.
Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome. Puhr, HC; Pablik, E; Berghoff, AS; Jomrich, G; Schoppmann, SF; Preusser, M; Ilhan-Mutlu, A. ESMO Open. 2020 Mar;5(2):e000623. PMID: 32188713
Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility—a safety and efficacy study. Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, Schoppmann SF. Surg Endosc. 2019 Nov;33(11):3623-3628. PMID: 30671665
A diagnostic algorithm that combines quantitative 18 F-FDG PET parameters and contrast-enhanced CT improves posttherapeutic locoregional restaging and prognostication of survival in patients with esophageal cancer. Tamandl D, Fueger B, Haug A, Schmid R, Stift J, Schoppmann SF, Ilhan-Mutlu A, Ba-Ssalamah A. Clin Nucl Med. 2019 Jan;44(1):e13-e21. PMID: 30418211
Persistent dysphagia is a rare problem after laparoscopic Nissen fundoplication. Nikolic M, Schwameis K, Semmler G, Asari R, Semmler L, Steindl A, Mosleh BO, Schoppmann SF. Surg Endosc. 2019,33(4),pp. 1196-1205. PMID: 30171395
High mean corpuscular volume predicts poor outcome for patients with gastroesophageal adenocarcinoma. Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, Asari R, Schoppmann SF. Annals of Surgical Oncology 2019,26(4),pp.976-985 PMID: 30706229
Modern esophageal function testing and gastroesophageal reflux disease in morbidly-obese patients. Kristo I, Paireder M, Jomrich G, Felsenreich DM, Nikolic M, Langer FB, Prager G, Schoppmann SF. Obes Surg. 2019 Nov;29(11):3536-3541. PMID: 31201693
Expression of FGF8, FGF18 and FGFR4 in Gastroesophageal Adenocarcinomas. Jomrich G, Hudec X, Harpain F, Winkler D, Timelthaler G, Mohr T, Marian B, Schoppmann SF. Cells 2019 Sep 16;8(9). pii: E1092. doi: 10.3390/cells8091092. PMID:31527546
The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, Kenner L. Cells. 2019 Oct 30;8(11):1357. PMID: 31671695
Ineffective Esophageal Motility in Patients with GERD is no Contraindication for Nissen Fundoplication. Nikolic M, Schwameis K, Kristo I, Paireder M, Matic A, Semmler G, Semmler L, Schoppmann SF. World J Surg 2019 Oct 11. PMID: 31605176
Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study. Paireder M, Asari R, Kristo I, Rieder E, Zacherl J, Kabon B, Fleischmann E, Schoppmann SF. European Surgery - Acta Chirurgica Austriaca 2018, 50 (6), pp. 249-255. PMID: 30546384
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction. Jomrich G, Hollenstein M, John M, Baierl A, Paireder M, Kristo I, Ilhan-Mutlu A, Asari R, Preusser M, Schoppmann SF. Oncotarget 2018, 9 (6), pp. 6968-6976. PMID: 29467943
MK2 and ETV1 are prognostic factors in esophageal adenocarcinomas. Jomrich G, Maroske F, Stieger J, Preusser M, Ilhan-Mutlu A, Winkler D, Kristo I, Paireder M, Schoppmann SF. Journal of Cancer 2018,9(3),pp.460-468. PMID:29483950
Swallowing MRI—a reliable method for the evaluation of the postoperative gastroesophageal situs after Nissen fundoplication. Arnoldner MA, Kristo I, Paireder M, Cosentini EP, Schima W, Weber M, Schoppmann SF, Kulinna-Cosentini C. Eur Radiol. 2019 Aug;29(8):4400-4407. PMID: 30421012
Radiofrequency ablation in patients with large cervical heterotopic gastric mucosa and globus sensation: Closing the treatment gap. Kristo I, Rieder E, Paireder M, Schwameis K, Jomrich G, Dolak W, Parzefall T, Riegler M, Asari R, Schoppmann SF. Digestive Endoscopy 2018, 30(2),pp.212-218. PMID: 28884487
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis. Ilhan-Mutlu, A., Taghizadeh, H., Beer, A., Dolak, W., Ba-Ssalamah, A., Schoppmann, S.F., Hejna, M., Birner, P., Preusser, M. Cancer Biol Ther. 2018 Mar 4;19(3):169-174. PMID: 29252101
Dysphagia severity is related to the amplitude of distal contractile integral in patients with Jackhammer esophagus. Kristo I, Schwameis K, Paireder M, Jomrich G, Kainz A, Schoppmann SF. Neurogastroenterol Motil. 2018 May;30(5):e13276. PMID:29266608
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma. Kollmann D, Ignatova D, Jedamzik J, Chang Y-T, Jomrich G, Baierl A, Kazakov D, Michal M, French LE, Hoetzenecker W, Schatton T, Asari R, Preusser M, Gnant M, Guenova E, Schoppmann SF. Oncoimmunology. 2018 Mar 13;7(6):e1435226. PMID: 29872575
Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected. Kappel-Latif S, Zacherl J, Hejna M, Westerhoff M, Tamandl D, Ba-Ssalamah A, Mittlböck M, Wolf B, Wrba F, Kührer I, Pluschnig U, Schoppmann SF, Függer R, Zwrtek R, Glaser K, Karner J, Längle F, Wenzl E, Roka R, Öfner D, Tschmelitsch J, Hold M, Keil F, Gnant M, Kandioler D, Kandioler D, the Pancho trialists and for the Medical University of Vienna p53 research group. Eur Surg. 2018;50(4):160-166. PMID: 30559831
Electrical Stimulation of the Lower Esophageal Sphincter to Treat Gastroesophageal Reflux After POEM. Rieder E, Paireder M, Kristo I, Schwameis K, Schoppmann SF. Surgical Innovation 2018, 25(4),pp.346-349. PMID:29742979
Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease. Schwameis K, Nikolic M, Morales Castellano DG, Steindl A, Macheck S, Kristo I, Zörner B, Schoppmann SF. World Journal of Surgery 2018, 42(10),pp.3263-3269. PMID:29619511
Crural closure improves outcomes of magnetic sphincter augmentation in GERD patients with hiatal hernia. Schwameis K, Nikolic M, Castellano DGM, Steindl A, Macheck S, Riegler M, Kristo I, Zörner B, Schoppmann SF. Sci Rep. 2018 May 9;8(1):7319. PMID: 29743599
Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors. Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, Jomrich G, Schoppmann SF. Sci Rep. 2018 Jul 2;8(1):9949. PMID: 29967357
Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer? Schoppmann SF, Kristo I, Riegler M. Transl Gastroenterol Hepatol. 2018 Dec 5;3:101. PMID: 30701208
Alternative therapies for GERD: a way to personalized antireflux surgery. Rieder E, Riegler M, Simić AP, Skrobić OM, Bonavina L, Gurski R, Paireder M, Castell DO, Schoppmann SF. Ann N Y Acad Sci. 2018 Dec;1434(1):360-369. PMID: 29774563
No Difference of the Systemic Immune-Inflammation Index as Prognostic Factor for Patients with Adenocarcinoma of the Gastroesophageal Junction With or Without Neoadjuvant Treatment. Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Gnant M, Schoppmann SF. Journal of the American College of Surgeons 2018, 227 (4), pp. S245-S246. DOI: https://doi.org/10.1016/j.jamcollsurg.2018.07.642